Finance
Results: 433-444 of 42358

Pierre Fabre Laboratories receives CHMP positive opinion for BRAFTOVI® (encorafenib) in combination with cetuximab and FOLFOX (fluorouracil, leucovorin, and oxaliplatin) for the first-line treatment of adult patients with BRAFV600E-mutant metastatic colorectal cancer (mCRC)

ZOE Energy Storage Partners with Local Saudi Ally to Build Kingdom's First World-Class Battery Storage Manufacturing Base

BioArctic's partner Eisai presents sales simulation of potential future sales of Leqembi® at its Investor Relations Day

XCMG Chairman Yang Dongsheng Joins Xuzhou Delegation on Economic and Trade Visits to Indonesia and Australia






